- $754.15m
- $866.26m
- $66.40m
- 43
- 20
- 55
- 33
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 4.6 | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 11.36 | ||
EV to EBITDA | 35.95 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 7.14% | ||
Return on Equity | 9.96% | ||
Operating Margin | 33.19% |
Financial Summary
Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | n/a | n/a | 1.2 | 44.71 | 66.4 | n/a | n/a | 643.88% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | +217343.48 | -60.85 | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Abacus Life, Inc. is a vertically integrated alternative asset manager and market maker, specializing in longevity and actuarial technology. The Company’s Portfolio Servicing segment provides policy services to customers on a contract basis. Its Active Management segment buys, sells and trades policies and maintains policies until receipt of death benefits. Its Originations segment originates life insurance policy settlements between investors or buyers, and the sellers, who is often the original policy owner. The policies are purchased from owners or other providers through advisors, brokers or directly through the owner. It originates policies through three primary origination channels (Agents/Financial Advisors, Direct-to-Consumers, Life Settlement Brokers) and Third-Party Intermediaries, screens them for eligibility by verifying that the policy is in force, obtaining consents and disclosures, and submitting cases for life expectancy estimates.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- May 22nd, 2020
- Public Since
- July 23rd, 2020
- No. of Shareholders
- 12
- No. of Employees
- 102
- Sector
- Insurance
- Industry
- Financials
- Exchange
- NASDAQ Capital Market
- Shares in Issue
- 63,694,758
- Address
- 2101 Park Center Drive, Suite 200, ORLANDO, 32835
- Web
- https://eastresources.com/
- Phone
- +1 5618263620
- Auditors
- Grant Thornton LLP
Upcoming Events for ABL
Q1 2024 Abacus Life Inc Earnings Call
Q2 2024 Abacus Life Inc Earnings Release
Similar to ABL
American Coastal Insurance
NASDAQ Capital Market
Cheche
NASDAQ Capital Market
Conifer Holdings
NASDAQ Capital Market
GoHealth
NASDAQ Capital Market
Hengguang Holding Co
NASDAQ Capital Market
FAQ
As of Today at 19:00 UTC, shares in Abacus Life are trading at $11.84. This share price information is delayed by 15 minutes.
Shares in Abacus Life last closed at $11.84 and the price had moved by +15.06% over the past 365 days. In terms of relative price strength the Abacus Life share price has underperformed the S&P500 Index by -4.25% over the past year.
There is no consensus recommendation for this security.
Abacus Life does not currently pay a dividend.
Abacus Life does not currently pay a dividend.
Abacus Life does not currently pay a dividend.
To buy shares in Abacus Life you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $11.84, shares in Abacus Life had a market capitalisation of $754.15m.
Here are the trading details for Abacus Life:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: ABL
Based on an overall assessment of its quality, value and momentum Abacus Life is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Abacus Life. Over the past six months, its share price has outperformed the S&P500 Index by +61.87%.
As of the last closing price of $11.84, shares in Abacus Life were trading +32.47% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Abacus Life PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $11.84.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Abacus Life's directors